Prevention & care
Blood glucose meters: finger-stick measurements, strips, error and diagnostic limits
On this page
A blood glucose meter is a test system: a handheld reader, compatible test strips and a small blood sample, usually from a fingertip. It measures glucose concentration at that moment, often displayed in mg/dL or mmol/L. The number is an estimate affected by the system and how the sample is collected.[1]
A home meter, CGM and laboratory test are different
MedlinePlus distinguishes laboratory glucose tests from ongoing home checks. Fasting plasma glucose samples one standardized moment; an oral glucose tolerance test examines response to a standardized drink; HbA1c reflects a longer period. These tests answer different diagnostic questions. A home reading taken after an ordinary meal does not recreate a laboratory tolerance-test protocol. Screening, confirming a diagnosis and monitoring established diabetes require different interpretation. The timing, symptoms and clinical context matter in addition to the displayed concentration.[2]
| Method or term | What it describes | Main limitation |
|---|---|---|
| Finger-stick meter | A small capillary sample at one time | Technique, strip and system-specific error[1] |
| Fasting laboratory glucose | A standardized diagnostic sample | Preparation and clinical confirmation matter[2] |
| Tolerance test | Response to a standardized glucose drink | Not equivalent to an ordinary meal experiment[2] |
The meter and strips must work as a system
FDA describes checking compatibility, expiration, storage conditions and the required sample size. A strip that physically fits is not necessarily chemically compatible. Wash and dry hands, because food or sugar contamination can alter the result; collect the sample as instructed rather than trying to correct a reading mathematically afterward. Heat and humidity can damage strips, and inadequate blood can affect performance. Control solution checks whether the system works within its specified control range, not whether the person’s blood glucose is healthy.[3]
Evidence & uncertainty
Useful monitoring depends on accurate technique and an agreed care plan. Performance requirements, laboratory diagnosis and evidence that monitoring improves treatment are distinct questions. Small differences between readings should not automatically be interpreted as a biological event.[4]
Selected-source overview · Independent review pendingPublished questions
Can one home reading diagnose diabetes?
Selected-source overview · Independent review pending. Read the evidence context.
Laboratory glucose testing uses defined protocols and clinical interpretation. An ordinary home check does not reproduce fasting or tolerance-test conditions and cannot independently establish a diagnosis.[2]
Evidence behind this answer
- Blood Glucose Test
agency guidance · Date not stated
Original official page or original full-text article: relevant passages inspected; no independent expert review. · Laboratory test purposes, preparation, interpretation and home monitoring
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do clean-looking fingers need washing?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. FDA notes that even small amounts of food or sugar can affect a reading. Follow the meter’s sample-collection directions.[3]
Evidence behind this answer
- Blood Glucose Meters: Getting the Most Out of Your Meter
agency guidance · Date not stated
Original official page or original full-text article: relevant passages inspected; no independent expert review. · Preparing, sample collection, maintenance and control solution
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does FDA clearance mean every result is exact?
Selected-source overview · Independent review pending. Read the evidence context.
No. Performance studies evaluate errors across samples and users. Clearance is specific to the submitted system and intended conditions.[4]
Evidence behind this answer
- Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use
agency guidance · 2020
Official guidance landing page and study-scope text inspected. Complete numerical performance tables in downloadable guidance not extracted. · September 2020 home-use guidance scope; performance-study purpose
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can an old accuracy study identify today’s best meter?
Selected-source overview · Independent review pending. Read the evidence context.
No. The 18-system study concerns earlier devices and lots. It supports checking model-specific evidence and current surveillance, not a permanent brand ranking.[5]
Evidence behind this answer
- Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
original research or professional guidance · 2018
Original abstract retrieved through indexed search; direct PubMed open returned no readable text. No full protocol or current-brand ranking extracted. · Original indexed abstract: 18 systems, three studies, prespecified criterion
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is testing the forearm equivalent during a rapid change?
Selected-source overview · Independent review pending. Read the evidence context.
Not necessarily. FDA warns that alternative sites can differ from fingertip results when glucose changes quickly; the particular instructions specify appropriate use.[1]
Evidence behind this answer
- Blood Glucose Monitoring Devices
agency guidance · Date not stated
Original official page or original full-text article: relevant passages inspected; no independent expert review. · Definition; selection; physiological, chemical and environmental interference; alternative sites
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does LO mean a glucose value of zero?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA explains that LO or HI can indicate a value outside the device’s measurable range. The display requires the device-specific care response.[6]
Evidence behind this answer
- How to Safely Use Glucose Meters and Test Strips for Diabetes
agency guidance · 2023
Original official page or original full-text article: relevant passages inspected; no independent expert review. · Secondhand strips; control checks; HI/LO; infection-safe use
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What should I ask about the purpose of finger-stick monitoring?
Selected-source overview · Independent review pending. Read the evidence context.
Ask how the results will inform care and who will review them. Trials tested different populations and support packages; neither provides a personal instruction to stop, start or change prescribed checks.[7][8]
Evidence behind this answer
- Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial
Pragmatic open-label randomized trial · 2017
Original full text retrieved; complete abstract and selected methods/discussion/disclosures read · Abstract; eligibility; patient/clinician training; discussion and limitations; funding/disclosures - Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program study
Cluster-randomized active-comparator trial · 2011
Original full text retrieved; complete abstract and selected methods/limitations/funding read · Abstract; practice randomization; enhanced care and structured package; strengths/weaknesses and disclosures
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Accuracy requirements describe a distribution of errors
FDA’s over-the-counter guidance concerns performance studies for home use by lay users. Accuracy is evaluated against a comparison method across multiple samples, ranges and users. Passing a submission criterion does not mean every result is exact, nor does it validate a different strip, storage condition or user population. The same absolute difference can have different implications at low and high glucose levels. This page therefore does not turn a permitted analytical error into an acceptable treatment error or a universal correction factor.[4]
Independent testing can expose model differences
Klonoff and colleagues tested 18 marketed systems in three accuracy studies representing an earlier US market. Only six met their prespecified accuracy criterion in all three studies. This is evidence about those tested products, lots, reference comparisons and dates, rather than a current shopping ranking. It also illustrates why regulatory clearance and continued performance surveillance are different tasks. Accuracy findings cannot by themselves prove how much a meter improves clinical outcomes; outcome benefit depends on what the information changes in care.[5]
Accurate readings do not automatically improve patient outcomes
The 2017 MONITOR trial randomized 450 adults with type 2 diabetes who were not using insulin to no routine checks or daily finger-stick monitoring, with or without tailored meter messages. At one year it found no clear benefit in HbA1c or health-related quality of life. Patients and clinicians had received training; clinicians received summaries. Testing adherence declined, and the trial did not settle every medication-change or safety situation. Its findings cannot be transferred to insulin users.[7]
A structured care programme tested something more specific
The 2011 STeP study randomized primary-care practices caring for 483 adults with inadequately controlled, non-insulin-treated type 2 diabetes. Both groups received enhanced usual care; the structured group added organized glucose profiles, patient and clinician training, and treatment-review support. HbA1c improved more with that package. The study could not isolate testing from its other components or establish whether all recommended treatment changes occurred. A glucose outcome does not itself demonstrate fewer complications.[8]
User physiology and environment can distort a result
FDA lists dehydration, anemia or extreme hematocrit, some medications or supplements, altitude, temperature and humidity as potential sources of interference, depending on the system. Different strip chemistries need not respond identically. Blood from an alternative site may lag behind a fingertip during rapid glucose changes. A mismatch between symptoms and a meter should therefore prompt the established clinical response and appropriate checking; a reassuring display alone cannot settle what is happening. Device instructions are more relevant than an online list applied to every model.[1]
Cost, access and safety must be considered together
FDA advises purchasing new, unopened strips rather than secondhand supplies, whose storage, expiration or labeling may be uncertain. Its consumer guidance also explains that HI or LO can mean outside the meter’s measurement range, not a precise value. Follow cleaning and disinfection instructions and do not share a single-user system. Affordability is a real access issue, but assuming every cheaper strip is interchangeable can introduce measurement and infection risks. A clinician or manufacturer can clarify alternatives compatible with the particular system.[6]
Discuss the purpose and response plan
These studies involved different participants, monitoring patterns and care packages; they were not a direct comparison of the two programmes. Ask what a reading will change, who reviews the pattern and which safety plan applies. Do not change prescribed monitoring from a trial summary.[7][8]
References
- Blood Glucose Monitoring Devices
Agency guidance
US FDA · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
Cited sections: Definition; selection; physiological, chemical and environmental interference; alternative sitesPublication date is distinguished from this retrieval date.
- Blood Glucose Test
Agency guidance
MedlinePlus / US National Library of Medicine · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
Cited sections: Laboratory test purposes, preparation, interpretation and home monitoringPublication date is distinguished from this retrieval date.
- Blood Glucose Meters: Getting the Most Out of Your Meter
Agency guidance
US FDA · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
Cited sections: Preparing, sample collection, maintenance and control solutionPublication date is distinguished from this retrieval date.
- Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use
Agency guidance
US FDA · Content/publication date: 2020
Accessed: 2026-10-13 UTC · Official guidance landing page and study-scope text inspected. Complete numerical performance tables in downloadable guidance not extracted.
Cited sections: September 2020 home-use guidance scope; performance-study purposePublication date is distinguished from this retrieval date.
- Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Original research or professional guidance
Klonoff DC and colleagues · Content/publication date: 2018
Accessed: 2026-10-13 UTC · Original abstract retrieved through indexed search; direct PubMed open returned no readable text. No full protocol or current-brand ranking extracted.
Cited sections: Original indexed abstract: 18 systems, three studies, prespecified criterionPublication date is distinguished from this retrieval date.
- How to Safely Use Glucose Meters and Test Strips for Diabetes
Agency guidance
US FDA · Content/publication date: 2023
Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
Cited sections: Secondhand strips; control checks; HI/LO; infection-safe usePublication date is distinguished from this retrieval date.
- Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial
Pragmatic open-label randomized trial
Young and colleagues; MONITOR trial · Content/publication date: 2017
Accessed: 2026-10-20 UTC · Original full text retrieved; complete abstract and selected methods/discussion/disclosures read
Cited sections: Abstract; eligibility; patient/clinician training; discussion and limitations; funding/disclosuresPCORI/NIH funded; UNC disclosed licensing the messaging algorithm to Telcare. Selected non-insulin population and declining adherence limit transfer.
- Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program study
Cluster-randomized active-comparator trial
Polonsky and colleagues; STeP study · Content/publication date: 2011
Accessed: 2026-10-20 UTC · Original full text retrieved; complete abstract and selected methods/limitations/funding read
Cited sections: Abstract; practice randomization; enhanced care and structured package; strengths/weaknesses and disclosuresRoche Diagnostics funded the study; several authors were employees or consultants. Care-package components were not separately randomized.
Scope & review
- Population
- General readers; study populations and intended device uses are specified
- Exposure or intervention
- Blood glucose meters: finger-stick measurements, strips, error and diagnostic limits
- Comparison
- Source-specific tests, device methods and usual-care comparisons
- Outcomes
- Measurement validity, interpretation, practical limits and source-specific health outcomes
- Timeframe
- Historical and contemporary sources checked 2026-10-13
- Jurisdiction
- US guidance and explicitly identified international studies; laboratory and device requirements differ
Selected-source educational explanation. Definitions, source findings and editorial interpretation are distinguished; no exhaustive search, independent systematic synthesis or qualified medical review completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added a selected-source educational explanation in edition 4.1; independent medical review remains pending.
- 2026-10-20 UTC: Added supported foundational, practical and evidence explanations after full target-body and relevant adjacent-coverage checks. Original sections, questions and sources preserved as exact prefixes; qualified review pending.
What this article still leaves open
- Independent medical review and a comprehensive literature synthesis remain unfinished.
- Individual test interpretation, current brand ranking and personalized treatment decisions are outside this explainer.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.